The roles of phytochemicals in bronchial asthma

Molecules

Volumn 15, Issue 10, 2010, Pages 6810-6834

  Park, Hee Sun ^a   Kim, So Ri ^b   Kim, Ju Ock ^a   Lee, Yong Chul ^b  

^a Chungnam National University   (South Korea)

^b Jeonbuk National University   (South Korea)

Author keywords

Antioxidants; Bronchial asthma; Plant

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; ASTHMA; CHEMICAL STRUCTURE; CHEMISTRY; CLINICAL TRIAL (TOPIC); HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYTOTHERAPY; PLANT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASTHMA; CLINICAL TRIALS AS TOPIC; HUMANS; MOLECULAR STRUCTURE; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS; REACTIVE OXYGEN SPECIES;

EID: 78149418353     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15106810     Document Type: Article

References (186)

1. Manson, M.M.; Farmer, P.B.; Gescher, A.; Steward, W.P. Innovative agents in cancer prevention. Recent Results Cancer Res. 2005, 166, 257-275.
2. Park, H.S.; Kim, S.R.; Lee, Y.C. Impact of oxidative stress on lung diseases. Respirology 2009, 14, 27-38.
3. Nohl, H.; Kozlov, A.V.; Gille, L.; Staniek, K. Cell respiration and formation of reactive oxygen species: Facts and artefacts. Biochem. Soc. Trans. 2003, 31, 1308-1311.
4. Liu, P.L.; Chen, Y.L.; Chen, Y.H.; Lin, S.J.; Kou, Y.R. Wood smoke extract induces oxidative stress-mediated caspase-independent apoptosis in human lung endothelial cells: Role of AIF and EndoG. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289, L739-L749.
5. Vayssier-Taussat, M.; Camilli, T.; Aron, Y.; Meplan, C.; Hainaut, P.; Polla, B.B.; Weksler, B. Effects of tobacco smoke and benzo[a]pyrene on human endothelial cell and monocyte stress responses. Am. J. Physiol. Heart Circ. Physiol. 2001, 280, H1293-H1300.
6. Wilson, M.; Lightbody, J.H.; Donaldson, K.; Sales, J.; Stone, V. Interactions between ultrafine particles and transition metals in vivo and in vitro. Toxicol. Appl. Pharmacol. 2002, 84, 172-179.
7. Henricks, P.A.; Nijkamp, F.P. Reactive oxygen species as mediators in asthma. Pulm. Pharmacol. Ther. 2001, 14, 409-420.
8. Halliwell, B.; Gutteridge, J.M.; Cross, C.E. Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med. 1992, 119, 598-620.
9. MacNee, W. Oxidative stress and lung inflammation in airway disease. Eur. J. Pharmacol. 2001, 429, 195-207.
10. Repine, J.E.; Bast, A.; Lankhorst, I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am. J. Respir. Crit. Care Med. 1997, 156, 341-357.
11. Dworski, R. Oxidant stress in asthma. Thorax 2000, 55, S51-S53.
12. Kay, A.B. Asthma and inflammation. J. Allergy Clin. Immunol. 1991, 87, 893-910.
13. Bousquet, J.; Jeffery, P.K.; Busse, W.W.; Johnson, M.; Vignola, A.M. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000, 161, 1720-1745.
14. Barnes, P.J. Reactive oxygen species in asthma. Eur. Respir. Rev. 2000, 10, 240-243.
15. Schauer, U.; Leinhaas, C.; Jäger, R.; Rieger, C.H. Enhanced superoxide generation by eosinophils from asthmatic children. Int. Arch. Allergy Appl. Immunol. 1991, 96, 317-321.
16. Teramoto, S.; Shu, C.Y,; Ouchi, Y.; Fukuchi, Y. Increased spontaneous production and generation of superoxide anion by blood neutrophils in patients with asthma. J. Asthma 1996, 33, 149-155.
17. Rochelle, L.G.; Fischer, B.M.; Adler, K.B. Concurrent production of reactive oxygen and nitrogen species by airway epithelial cells in vitro. Free Radic. Biol. Med. 1998, 24, 863-868.
18. Bruijnzeel, P.L.; Koenderman, L.; Kok, P.T.; Hameling, M.L.; Verhagen, J. Platelet activating factor (PAF-acether) induced leukotriene C4 formation and luminal dependent chemiluminescence of human eosinophils. Pharm. Res. Comm. 1986, 18, 61-69.
19. Chihara, J.; Hayashi, N.; Kakazu, T.; Yamamoto, T.; Kurachi, D.; Nakajima, S. RANTES augments radical oxygen products from eosinophils. Int. Arch. Allergy Immunol. 1994, 104, 52-53.
20. Tenscher, K.; Metzner, B.; Schopf, E.; Norgauer, J.; Czech, W. Recombinant human eotaxin induces oxygen radical production, upregulation in human eosinophils via a pertussis toxinsensitive heterotrimeric guanine nucleotide-binding protein. Blood 1996, 88, 3195-3199.
21. Nagata, M., Sedgwick, J.B.; Vrtis, R.; Busse, W.W. Endothelial cells upregulate eosinophil superoxide generation via VCAM-1 expression. Clin. Exp. Allergy 1998, 29, 550-561.
22. Rankin, J.A.; Harris, P.; Ackerman, S.J. The effect of eosinophil granule major basic protein on lung-macrophage superoxide anion generation. J. Allergy Clin. Immunol. 1992, 89, 746-752.
23. Health effects of outdoor air pollution. Committee of the environmental and occupational health assembly of the American Thoracic Society. Am. J. Respir. Crit. Care Med. 1996, 153, 3-50.
24. Rahman, I.; MacNee, W. Reactive oxygen species. In Asthma and COPD; Barnes, P.J., Drazen, J., Rennard, S., Thomson, N., Eds.; Academic Press: London, UK, 2002; pp.243-254.
25. Barnes, P.J.; Chung, K.F.; Page, C.P. Inflammatory mediators of asthma: An update. Pharmacol. Rev. 1998, 50, 515-596.
26. Barnes, P.J. Cytokines as mediators of chronic asthma. Am. J. Respir. Crit. Care Med. 1994, 150, 42-49.
27. Hulsmann, A.R.; Raatgeep, H.R.; den Hollander, J.C.; Stijnen, T.; Saxena, P.R.; Kerrebijn, K.F.; de Jongste, J.C. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am. J. Respir. Crit. Care Med. 1994, 149, 519-525.
28. Cortijo, J.; Marti-Cabrera, M.; de la Asuncion, J.G.; Pallardó, F.V.; Esterase, A.; Bruseghini, L.; Viña, J.; Morcillo, E.J. Contraction of human airways by oxidative stress protection by Nacetylcysteine. Free Radic. Biol. Med. 1999, 27, 392-400.
29. Sadeghi-Hashjin, G.; Folkerts, G.; Henricks, P.A.; Verheyen, A.K.; van der Linde, H.J.; van Ark, I.; Coene, A.; Nijkamp, F.P. Peroxynitrite induces airway hyperresponsiveness in guinea pigs in vitro and in vivo. Am. J. Respir. Crit. Care Med. 1996, 153, 1697-1701.
30. Lee, K.S.; Kim, S.R.; Park, S.J.; Park, H.S.; Min, K.H.; Lee, M.H.; Jin, S.M.; Jin, G.Y.; Yoo, W.H.; Lee, Y.C. Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am. J. Respir. Cell Mol. Biol. 2006, 35, 190-197.
31. Adam, L.; Bouvier, M.; Jones, T.L. Nitric oxide modulates beta(2)-adrenergic receptor palmitoylation and signaling. J. Biol. Chem. 1999, 274, 26337-26343.
32. Owen, S.; Pearson, D.; Suarez-Mendez, V.; O'Driscoll, R.; Woodcock, A. Evidence of free-radical activity in asthma. N. Engl. J. Med. 1991, 325, 586-587.
33. Cho, Y.J.; Seo, M.S.; Kim, J.K.; Lim, Y.; Chae, G.; Ha, K.S.; Lee, K.H. Silica-induced generation of reactive oxygen species in Rat2 fibroblasts: Role in activation of mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 1999, 262, 708-712.
34. Ding, M.; Shi, X.; Dong, Z.; Chen, F.; Lu, Y.; Castranova, V.; Vallyathan, V. Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK. J. Biol. Chem. 1999, 274, 30611-30616.
35. Lopez-Ilasaca, M.; Crespo, P.; Pellici, P.G.; Gutkind, J.S.; Wetzker, R. Linkage of G proteincoupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science 1997, 275, 394-397.
36. Lee, Y.C.; Lee, K.S.; Park, S.J.; Park, H.S.; Lim, J.S.; Park, K.H.; Im, M.J.; Choi, I.W.; Lee, H.K.; Kim, U.H. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid. FASEB J. 2004, 18, 1917-1919.
37. Lee, K.S.; Park, H.S.; Park, S.J.; Kim, S.R.; Min, K.H.; Jin, S.M.; Li, L.; Lee, Y.C. An antioxidant modulates expression of receptor activator of NF-B in asthma. Exp. Mol. Med. 2006, 38, 217-229.
38. Schenk, H.; Klein, M.; Erdbrugger, W.; Drfge, W.; Schulze-Osthoff, K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-?B and AP-1. Proc. Natl. Acad. Sci. USA 1994, 91, 1672-1676.
39. Harper, R.; Wu, K.; Chang, M.M.; Yoneda, K.; Pan, R.; Reddy, S.P.; Wu, R. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by Nacetyl- cysteine and glutathione. Am. J. Respir. Cell Mol. Biol. 2001, 25, 178-185.
40. Shaulian, E.; Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 2002, 4, E131-E136.
41. Tikoo, K.; Lau, S.S.; Monks, T.J. Histone H2 phosphorylation is coupled to poly(ADPribosylation) during reactive oxygen species-induced cell death in renal proximal tubular epithelial cells. Mol. Pharmacol. 2001, 60, 394-402.
42. Zor, U.; Ferber, E.; Gergely, P.; Szücs, K; Dombrádi, V.; Goldman, R. Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: Potentiation by vanadate. Biochem. J. 1993, 295, 879-888.
43. Goldman, R.; Ferber, E.; Zort, U. Reactive oxygen species are involved in the activation of cellular phospholipase A2. FEBS Lett. 1992, 309, 190-192.
44. Liu, T.; Castro, S.; Brasier, A.R.; Jamaluddin, M.; Garofalo, R.P.; Casola, A. Reactive oxygen species mediate virus-induced STAT activation: Role of tyrosine phosphatase. J. Biol. Chem. 2004, 279, 2461-2469.
45. Hsu, H.Y.; Wen, M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 2002, 277, 22131-22139.
46. Seifried, H.E.; Anderson, D.E.; Fisher, E.I.; Milner, J.A. A review of the interaction among dietary antioxidants and reactive oxygen species. J. Nutr. Biochem. 2007, 18, 567-579.
47. Chaudiere, J.; Ferrari-Iliou, R. Intracellular antioxidants from chemical to biochemical mechanisms. Food Chem. Toxicol. 1999, 37, 949-962.
48. Heffner, J.A.; Repine, J.E. State of the art: Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis. 1989, 140, 531-554.
49. Toth, K.M.; Clifford, D.P.; Berger, E.M.; White, C.W.; Repine, J.E. Intact human erythrocyte prevent hydrogen peroxide mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J. Clin. Invest. 1984, 74, 292-295.
50. Van Asbeck, B.S.; Hoidal, J.; Vercelloti, G.M.; Schwartz, B.A.; Moldow, C.F.; Jacob, H.S. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: Role of red cell glutathione. Science 1985, 227, 756-759.
51. Wood, L.G; Gibson, P.G.; Garg, M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J. 2003, 21, 177-186.
52. Devereux, G.; Seaton, A. Diet as a risk factor for atopy and asthma. J. Allergy Clin. Immunol. 2005, 115, 1109-1117.
53. Atkinson, C.J.; Nestby, R.; Fod, Y.Y.; Dodds, P.A. Enhancing beneficial antioxidants in fruits: A plant physiological perspective. BioFactors 2005, 23, 229-234.
54. Klein, B.P.; Kurilich, A.C. Processing effects on dietary antioxidants from plant foods. HortScience 2000, 35, 580-584.
55. Prior, R.L.; Cao, G. Antioxidant phytochemicals in fruits and vegetables: Diet and health implications. HortScience 2000, 35, 588-592.
56. Balsano, C.; Alisi, A. Antioxidant effects of natural bioactive compounds. Curr. Pharmaceu. Des. 2009, 15, 3063-3073.
57. Middleton, E.J.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
58. Williams, C.A.; Grayer, R.J. Anthocyanins and other flavonoids. Nat. Prod. Rep. 2004, 21, 539-573.
59. Hollman, P.C.; Katan, M.B. Health effects and bioavailability of dietary flavonols. Free Rad. Res. 1999, 31, S75-S80.
60. Harborne, J.B.; Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry 2000, 55, 481-504.
61. Schroeter, H.; Boyd, C.; Spencer, J.P.; Williams, R.J.; Cadenas, E.; Rice-Evans, C. MAPK signaling in neurodegeneration: Influences of flavonoids and of nitric oxide. Neurobiol. Aging 2002, 23, 861-880.
62. Rice-Evans, C. Flavonoid antioxidants. Curr. Med. Chem. 2001, 8. 797-807.
63. Polovka, M.; Brezova, V.; Stasko, A. Antioxidant properties of tea investigated by EPR spectroscopy. Biophys. Chem. 2003, 106, 39-56.
64. Shaheen, S.O.; Sterne, J.A.; Thompson, R.L.; Songhurst, C.E.; Margetts, B.M.; Burney, P.G. Dietary antioxidants and asthma in adults: Population-based case-control study. Am. J. Respir. Crit. Care Med. 2001, 164, 1823-1828.
65. Knekt, P.; Kumpulainen, J.; Jarvinen, R.; Rissanen, H.; Hellövaara, M.; Reunanen, A.; Hhakulinen, T.; Aromaa, A . Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 2002, 76, 560-568.
66. Middleton, E. The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids. J. Allergy Clin. Immunol. 1986, 78, 321-328.
67. Sloan, R.; Boran-Ragotzy, R.; Ackerman, S.J.; Drzewiecki, G.; Middleton, E. The effect of plant flavonoids on eosinophil degranulation. J. Allergy Clin. Immunol. 1991, 87, 282, abstract.
68. Li, R.R.; Pang, L.L.; Du, Q.; Shi, Y.; Dai, W.J.; Yin, K.S. Apigenin inhibits allergen-induced airway inflammation and switches immune response in a murine model of asthma. Immunopharmacol. Immunotoxicology 2010, in press.
69. Park, H.S.; Kim, S.Y.; Kim, S.R.; Lee, Y.C. Targeting abnomrla airway vasculatiry as a therapeutical strategy in asthma. Respirology 2010, 15, 459-471.
70. Oak, M.H.; El Bedoui, J.; Schini-Kerth, V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 2005, 16, 1-8.
71. Cao, Y.; Cao, R. Angiogenesis inhibited by drinking tea. Nature 1999, 398, 381.
72. Fang, J.; Zhou, Q.; Liu, L.Z.; Xia, C.; Hu, X.; Shi, X.; Jiang, B.H. Angiogenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression. Carcinogenesis 2007, 28, 858-864.
73. Liu, L.Z.; Fang, J.; Zhou, Q.; Hu, X.; Shi, X.; Jiang, B.H. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: Implication of chemoprevention of lung cancer. Mol. Pharmacol. 2005, 68, 635-643.
74. Fang, J.; Xia, C.; Cao, Z.; Zheng, J.Z.; Reed, E.; Jiang, B.H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005, 19, 342-353.
75. Mojžišová, G.; Mojžiš, J.; Pilátová, M.; Vohárová, V.; Varinská, L.; Perjesi, P.; Sarišský, M.; Mirossay, L. Antiproliferative and antiangiogenic effects of selected chalcones. Acta Pharmacol. Sin. 2006, 27, 338.
76. Mojžiš, J.; Varinská, L.; Perjesi P.G.; Mojžišová, G. Antiangiogenic effect of newly synthesized chalcones. Eur. J. Cancer 2007, 5, 87.
77. Mojzis, J.; Varinska, L.; Mojzisova, G.; Kostova, I.; Mirossay, L. Antiangiogenic effects of flavonoids and chalcones. Pharmacol. Res. 2008, 57, 259-265.
78. Oak, M.H. El Bedoui, J.; Schini-Kerth, V.B. Antiangiogenic properties of natural polyphenols from red wine and green tea. J. Nutr. Biochem. 2005, 16, 1-8.
79. Kurup, V.P.; Barrios, C.S. Immunomodulatory effects of curcumin in allergy. Mol. Nutr. Food Res. 2008, 52, 1031-1039.
80. Biswas, S.; Rahman, I. Modulation of steroid activity in chronic inflammation: A novel antiinflammatory role for curcumin. Mol. Nutr. Food Res. 2008, 52, 987-994.
81. Mortellini, R.; Foresti, R.; Bassi, R.; Green, C.J. Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 2000, 28, 1301-1312.
82. Brouet, I.; Ohshima, H.; Curcumin. An anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthetase in activated macrophages. Biochem. Biophys. Res. Commun. 1995, 206, 533-540.
83. Barnes, P.J. Histone deacetylase-2 and airway disease. Ther. Adv. Respir. Dis. 2009, 3, 235-243.
84. Meja, K.K.; Rajendrasozhan, S.; Adenuga, D.; Biswas, S.K.; Sundar, I.K.; Spooner, G.; Marwick, J.A.; Chakravarty, P.; Fletcher, D.; Whittaker, P.; et al. Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am. J. Respir. Cell Mol. Biol. 2008, 39, 312-323.
85. Bremner, P.; Heinrich, M. Natural products as targeted modulators of the nuclear factor-kappaB pathway. J. Pharm. Pharmacol. 2002, 54, 453-472.
86. de la Lastra, C.A.; Villegas, I. Resveratrol as an antioxidant and prooxidant agent: Mechanisms and clinical implications. Biochem. Soc. Trans. 2007, 35, 1156-1160.
87. Das, S.; Das, D.K. Resveratrol: A therapeutic promise for cardiovascular diseases. Recent Pat. Cardiovasc. Drug Discov. 2007, 2, 133-138.
88. Shankar, S.; Singh, G.; Srivastava, R.K. Chemoprevention by resveratrol: Molecular mechanisms and therapeutic potential. Front. Biosci. 2007, 12, 4839-4854.
89. Pirola, L.; Fröjdö, S. Resveratrol: One molecule, many targets. IUBMB Life 2008, 60, 323-332.
90. Leonard, S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003, 309, 1017-1026.
91. Das, D.K.; Maulik, N. Resveratrol in cardioprotection: A therapeutic promise of alternative medicine. Mol. Interven. 2006, 6, 36-47.
92. Youn, J.; Lee, J.S.; Na, H.K.; Kundu, J.K.; Surh, Y.J. Resveratrol and piceatannol inhibit iNOS expression and NF-kappaB activation in dextran sulfate sodium-induced mouse colitis. Nutr. Cancer 2009, 61, 847-854.
93. Li, T.; Wang, W.; Chen, H.; Li, T.; Ye, L. Evaluation of anti-leukemia effect of resveratrol by modulating STAT3 signaling. Int. Immunopharmacol. 2010, 10, 18-25.
94. Tang, X.; Zhang, Q.; Nishitani, J.; Brown, J.; Shi, S, Le, A.D. Overexpression of human papillomavirus type 16 oncoproteins enhances hypoxia-inducible factor 1 alpha protein accumulation and vascular endothelial growth factor expression in human cervical carcinoma cells. Clin. Cancer Res. 2007, 13, 2568-2576.
95. Wu, H.; Liang, X.; Fang, Y.; Qin, X.; Zhang, Y.; Liu, J. Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed. Pharmacother. 2008, 62, 613-621.
96. Park, S.Y.; Jeong, K.J.; Lee, J.; Yoon, D.S.; Choi, W.S.; Kim, Y.K.; Han, J.W.; Kim, Y.M.; Kim, B.K.; Lee, H.Y. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: Their inhibition by resveratrol. Cancer Lett. 2007, 258, 63-69.
97. Bourguignon, L.Y.; Xia, W.; Wong, G. Hyaluronan-mediated CD44 Interaction with p300 and SIRT1 Regulates ß-Catenin Signaling and NFkappaB-specific Transcription Activity Leading to MDR1 and Bcl-xL Gene Expression and Chemoresistance in Breast Tumor Cells. J. Biol. Chem. 2009, 284, 2657-2671.
98. Rachon, D.; Rimoldi, G.; Wuttke, W. In vitro effects of genistein and resveratrol on the production of interferon-gamma (IFNgamma) and interleukin-10 (IL-10) by stimulated murine splenocytes. Phytomedicine 2006, 13, 419-424.
99. Tao, H.Y.; Wu, C.F.; Zhou, Y.; Gong, W.H.; Zhang, X.; Iribarren, P.; Zhao, Y.Q.; Le, Y.Y.; Wang, J.M. The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes. Cell Mol. Immunol. 2004, 1, 50-56.
100. Wirleitner, B.; Schroecksnadel, K.; Winkler, C.; Schennach, H.; Fuchs, D. Resveratrol suppresses interferon-gamma-induced biochemical pathways in human peripheral blood mononuclear cells in vitro. Immunol. Lett. 2005, 100, 159-163.
101. Gao, X.; Deeb, D.; Media, J.; Divine, G.; Jiang, H.; Chapman, R.A.; Gautam, S.C. Immunomodulatory activity of resveratrol: Discrepant in vitro and in vivo immunological effects. Biochem. Pharmacol. 2003, 66, 2427-2435.
102. Gao, X.; Xu, Y.X.; Janakiraman, N.; Chapman, R.A.; Gautam, S.C. Immunomodulatory activity of resveratrol: Suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production. Biochem. Pharmacol. 2001, 62, 1299-1308.
103. Harikumar, K.B.; Aggarwal, B.B. Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7, 1020-1035.
104. Kolthur-Seetharam, U.; Dantzer, F.; McBurney, M.W.; de Murcia, G.; Sassone-Corsi, P. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 2006, 5, 873-877.
105. Alcaín, F.J.; Villalba, J.M. Sirtuin activators. Expert Opin. Ther. Pat. 2009, 19, 403-414.
106. Kim, G,Y.; Cho, H.; Ahn, S.C.; Oh, Y.H.; Lee, C.M.; Park, Y.M. Resveratrol inhibits phenotypic and functional maturation of murine bone marrow-derived dendritic cells. Int. Immunopharmacol. 2004, 4, 245-253.
107. Rao, A.V.; Rao, L.G. Carotenoids and human health. Pharmacol. Res. 2007, 55, 207-216.
108. Gallicchio, L.; Boyd, K.; Matanoski, G.; Tao, X.G.; Chen, L.; Lam, T.K.; Shiels, M.; Hammond, E.; Robinson, K.A.; Caulfield, L.E.; et al. Carotenoids and the risk of developing lung cancer: A systematic review. Am. J. Clin. Nutr. 2008, 88. 372-383.
109. Young, C.Y; Yuan, H.Q.; He, M.L.; Zhang, J.Y. Carotenoids and prostate cancer risk. Mini Rev. Med. Chem. 2008, 8, 529-537.
110. Melendez, G.V; Okani, E.T.; Kiertsman, B.; Roncada, M.J. Vitamin A status in children with pneumonia. Eur. J. Clin. Nutr. 1995, 49, 379-384.
111. Kukukbay, H.; Yakinci, C.; Kukukbay, F.Z.; Tutgut, M. Serum vitamin A and beta-carotene levels in children with recurrent acute respiratory infections and diarrhoea in Malarya. J. Trop. Pediatr. 1997, 43, 337-340.
112. Mayne, S.T. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J. 1996, 10, 690-701.
113. Mortensen, A.; Skibsted, L.H.; Truscott, T.G. The interaction of dietary carotenoids with radical species. Arch. Biochem. Biophys. 2001, 385, 13-19.
114. Schock, B.C.; Young, I.S.; Brown, V.; Fitch, P.S.; Shields, M.D.; Ennis, M. Antioxidants and oxidative stress in BAL fluid of atopic asthmatic children. Pediatr.Res. 2003, 53, 375-381.
115. Barasi, ME. Water soluble vitamins. In Human Nutrition; Arnold Publishers: London, UK, 1997; pp. 171-175.
116. Rice-Evans, C.A.; Sampson, J.; Bramley, P.M.; Holloway, D.E. Why do we expect carotenoids to be antioxidants in vivo? Free Radic. Res. 1997, 26, 381-398.
117. Patrick, L. Beta-carotene: The controversy continues. Altern. Med. Rev. 2000, 5, 530-545.
118. Wood, L.G.; Garg, M.L.; Blake, R.J.; Garcia-Caraballo, S.; Gibson, P.G. Airway and circulating levels of carotenoids in asthma and healthy controls. J. Am. Coll. Nutr. 2005, 24, 448-455.
119. Zachman, R.D. Role of vitamin A in lung development. J. Nutr. 1994, 125, 1634S-1638S.
120. Chandra, R.K.; Vyas, D. Vitamin A, immunocompetence and infection. Fed. Nutr. Bull. 1989, 11, 12-19.
121. Bloem, M.W.; Wedel, M.; Egger, R.J. Mild vitamin A deficiency and risk of respiratory tract diseases and diarrhea in preschool and school children in northeastern Thailand. Am. J. Epidemiol. 1990, 131, 332-339.
122. Villamor, E.; Fawzi, W.W. Vitamin A supplementation: Implications for morbidity and mortality in children. J. Infect. Dis. 2000, 182, S122-S133.
123. Niles, R.M. Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat. Res. 2004, 555, 81-96.
124. Sharoni, Y.; Danilenko, M.; Dubi, N.; Ben-Dor, A.; Levy, J. Carotenoids and transcription. Arch. Biochem. Biophys. 2004, 430, 89-96.
125. Karas, M.; Amir, H.; Fishman, D.; Danilenko, M.; Segal, S.; Nahum, A.; Koifmann, A.; Giat, Y.; Levy, J.; Sharoni, Y. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer 2000, 36, 101-111.
126. Riccioni, G.; Barbara, M.; Bucciarelli, T.; de Ilio, C.; D'Orazio, N. Antioxidant vitamin supplementation in asthma. Ann. Clin. Lab. Sci. 2007, 37, 96-101.
127. Retsky, K.L.; Chen, K.; Zeind, J.; Frei, B. Inhibition of copperinduced LDL oxidation by Vitamin C is associated with decreased copperbinding to LDL and 2-oxo-histidine formation. Free Radic. Biol. Med. 1999, 26, 90-98.
128. Cameron, E.; Pauling, L. Supplemental ascorbate in supportive treatment of cancer-prolongation of survival times in terminal human cancer. Part 1. Proc. Natl. Acad. Sci. USA 1976, 73, 3685-3689.
129. You, W.C.; Zhang, L.; Gail, M.H.; Chang, Y.S.; Liu, W.D.; Ma, J.L.; Li, J.Y.; Jin, M.L.; Hu, Y.R.; Yang, C.S.; et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl. Cancer Inst. 2000, 92, 1607-1612.
130. Knekt, P.; Jarvinen, R.; Seppanen, R.; Rissanen, A.; Aromaa, A.; Heinonen, O.P.; Albanes, D.; Heinonen, M.; Pukkala, E.; Teppo, L. Dietary antioxidants and the risk of lung-cancer. Am. J. Epidemiol. 1991, 134, 471-479.
131. Divisi, D.; Di Tommaso, S.; Salvemini, S.; Garramone, M.; Crisci, R. Diet and cancer. Acta Biomed. 2006, 77, 118-123.
132. Romieu, I.; Trenga, C. Diet and obstructive lung diseases. Epidemiol. Rev. 2001, 23, 268-287.
133. Allen, S.; Britton, J.R.; Leonardi-Bee, J.A. Association between antioxidant vitamins and asthma outcome measures: Systematic review and meta-analysis. Thorax 2009, 64, 610-619.
134. Catani, M.V.; Rossi, A.; Costanzo, A.; Sabatini, S.; Levrero, M.; Melino, G, Avigliano, L. Induction of gene expression via activator protein-1 in the ascorbate protection against UVinduced damage. Biochem. J. 2001, 356, 77-85.
135. Kaur, B.; Rowe, B.H.; Arnold, E. Vitamin C supplementation for asthma. Cochrane Database Syst. Rev. 2009, 1, CD000993.
136. Riccioni, G.; D'Orazio, N. The role of selenium, zinc and antioxidant vitamin supplementation in the treatment of bronchial asthma: Adjuvant therapy or not? Expert Opin. Investig. Drugs 2005, 14, 1145-1155.
137. Burton, G.W.; Ingold, K.U. Vitamin E as an in vitro and in vivo antioxidant. Ann. N.Y. Acad. Sci. 1989, 570, 7-22.
138. Atkinson, J.; Epand, R.F.; Epand, R.M. Tocopherols and tocotrienols in membranes: A critical review. Free Radic. Biol. Med. 2008, 44, 739-764.
139. De Luca, H.F.; Zierold, C. Mechanisms and functions of vitamin D. Nutr. Rev. 1998, 56, 4-10.
140. Moriguchi, S.; Muraga, M. Vitamin E and immunity. Vitam. Horm. 2000, 59, 305-336.
141. Pryor, W.A. Vitamin E and heart disease: Basic science to clinical intervention trials. Free Radic. Biol. Med. 2000, 28, 141-164.
142. Devarah, S.; Harris, A.; Jialal, I. Modulation of monocyte-macrophage function with alphatocopherol: Implications for atherosclerosis. Nutr. Rev. 2002, 60, 8-14.
143. Yoshikawa, T.; Yoshida, N. Vitamin E and leukocyte-endothelial cell interactions. Antioxid. Redox Signal 2000, 2, 821-825.
144. Kojo, S. Vitamin C. basic metabolism and its function as an index of oxidative stress. Curr. Med. Chem. 2004, 11, 1041-1064.
145. Pletsityi, K.D.; Vasipa, S.B.; Daydova, T.V.; Fomina, V.G. Vitamin E: Immunocorrecting effect in bronchial asthma patients. Vopr. Med. Khim. 1995, 41, 33-36.
146. Picado, C.; Deulofeu, R.; Lleonart, R.; Agusti, M.; Mullol, J.; Quintó, L.; Torra, M. Dietary. micronutrients/antioxidants and their relationship with bronchial asthma severity. Allergy 2001, 56, 43-49.
147. Troisi, R.J.; Willett, W.C.; Weiss, S.T.; Trichopoulos, D.; Rosner, B.; Speizer, F.E. A prospective study of diet and adult-onset asthma. Am. J. Respir. Crit. Care Med. 1995, 151, 1401-1408.
148. Trenga, C.; Koenig, J.Q,; Williams, P.V. Dietary antioxidants and ozone-induced bronchial hyperresponsiveness in adults with asthma. Arch. Environ. Health. 2001, 56, 242-249.
149. Pearson, P.J.; Lewis, S.A.; Britton, J.; Fogarty, A. Vitamin E supplements in asthma: A parallel group randomized placebo controlled trial. Thorax 2004, 59, 652-656.
150. Wiser, J.; Alexis, N.E.; Jiang, Q.; We, W.; Robinnette, C.; Roubey, R.; Peden, D.B. In vivo gamma tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects. Free Radic. Biol. Med. 2008, 45, 40-49.
151. Berdnikovs, S.; Abdala-Valencia, H.; McCary, C.; Somand, M.; Cole, R.; Garcia, A.; Bryce, P.; Cook-Mills, J.M. Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment. J. Immunol. 2009, 182, 4395-4405.
152. Wolf, G. How an increased intake of a-tocopherol can suppress the bioavailability of -tocopherol. Nutr. Rev. 2006, 64, 295-299.
153. Packer, L.; Suzuki, Y.J. Vitamin-E and alpha-lipoate - role in antioxidant recycling and activation of the NF-kappa B transcription factor. Mol. Aspects Med. 1993, 14, 229-239.
154. Bustamante, J.; Lodge, J.K.; Marcocci, L.; Tritschler, H.J.; Packer, L.; Rihn, B.H. Alpha-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med. 1998, 24, 1023-1039.
155. Cao, X.; Phillis, J.W. The free radical scavenger, alpha-lipoic acid, protects against cerebral ischemia-reperfusion injury in gerbils. Free Radic. Res. 1995, 23, 365-370.
156. Van Dam, P.S. Oxidative stress and diabetic neuropathy: Pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. 2002, 18, 176-184.
157. Ametov, A.S.; Barinov, A.; Dyck, P.J.; Hermann, R.; Kozlova, N.; Litchy, W.J.; Low, P.A.; Nehrdich, D.; Novosadova, M.; O'Brien, P.C.; et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoid acid: The SYDNEY trial. Diabetes Care 2003, 26, 770-776.
158. Ramakrishnan, N.; Wolfe, W.W.; Catravas, G.N. Radioprotection of hematopoietic tissues in mice by lipoic acid. Radic. Res. 1992, 130, 360-365.
159. Cho, Y.S.; Lee, J.C.; Lee, T.H.; Lee, E.Y.; Lee, K.U.; Park, J.Y.; Moon, H.B. Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J. Allergy Clin. Immunol. 2004, 114, 429-435.
160. Lee, K.S.; Park, H.S.; Park, S.J.; Kim, S.R.; Min, K.H.; Jin, S.M.; Park, K.H.; Kim, U.H.; Kim, C.Y.; Lee, Y.C. A prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma. Mol. Pharmacol. 2005, 68, 1281-1290.
161. Schwarz, S. Essentiality and metabolic functions of selenium. Med. Clin. North Am. 1976, 60, 745-758.
162. Saito, Y.; Sato, N.; Hirashima, M.; Takebe, G.; Nagasawa, S.; Takahashi, K. Domain structure of bi-functional selenoprotein. Biochem. J. 2004, 381, 841-846.
163. Rayman, M.P. The importance of selenium to human health. Lancet 2000, 356, 233-241.
164. Gromer, S.; Eubel, J.K.; Lee, B.L.; Jacob, J. Human selenoproteins at a glance. Cell Mol. Life Sci. 2005, 62, 2414-2437.
165. Anonymous. Selenium-monograph. Altern. Med. Rev. 2003, 8, 63-71.
166. Bainbridge, D.R. Use of (75Se)L-Selenomethionine as a label for lymphoid cells. Immunology 1976, 30, 135-144.
167. Gromer, S.; Eubel, J.K.; Lee, B.L.; Jacob, J. Human selenoproteins at a glance. Cell Mol. Life Sci. 2005, 62, 2414-2437.
168. Pretorius, E.; Oberholzer, H.M.; Vieira, W.A.; Smit, E. Ultrastructure of platelets and fibrin networks of asthmatic mice exposed to selenium and Withania somnifera. Anat. Sci. Int. 2009, 84, 210-217.
169. Jahnova, E.; Horvathova, M.; Gazdik, F.; Weissova, S. Effects of selenium supplementation on expression of adhesion molecules in corticoid-dependent asthmatics. Bratisl. Lek. Listy 2002, 103,12-16.
170. Brown, K.M.; Arthur, J.R. Selenium, selenoproteins and human health: A review. Public Health Nutr. 2001, 4, 593-599.
171. Horváthová, M.; Jahnová, E.; Gazdik, F. Effect of selenium supplementation in asthmatic subjects on the expression of endothelial cell adhesion molecules in culture. Biol. Trace Elem. Res. 1999, 69, 15-26.
172. Hoffmann, P.R.; Berry, M.J. The influence of selenium on immune responses. Mol. Nutr. Food Res. 2008, 52, 1273-1280.
173. Allam, M.F.; Lucena, R.A. Selenium supplementation for asthma. Cochrane Database Syst. Rev. 2009, 1, CD003538.
174. Riccioni, G. Plasma lycopene and antioxidant vitamins in asthma: The PLAVA study. J. Asthma 2007, 44, 429-432.
175. Ray, A.L.; Semba, R.D.; Walston, J.; Ferrucci, L.; Cappola, A.R.; Ricks, M.O.; Xue, Q.L.; Fried, L.P. Low serum selenium and total carotenoids predict mortality among older women living in the community: The women's health and aging studies. J. Nutr. 2006, 136, 172-176.
176. Hisama, M.; Matsuda, S.;Tanaka, T.; Shibayama, H.; Nomura, M.; Iwaki, M. Suppression of mutagens-induced SOS response by phytoncide solution using salmonella typhimurium TA 1535/pSK1002 umu Test. J. Oleo. Sci. 2008, 57, 381-390.
177. Aoshima, H.; Hamamoto, K. Potentiation of GABAA receptors expressed in Xenopus oocytes by perfume and phytoncide. Biosci. Biotechnol. Biochem. 1999, 63, 743-748.
178. Hossain, S.J.; Aoshima, H.; Koda, H.; Kiso, Y. Potentiation of the ionotropioc GABA receptor response by whiskey fragrance. J. Agric. Food Chem. 2002, 50, 6828-6834.
179. Li, Q.; Morimoto, K.; Inagaki, H.; Katsumata, M.; Hirata, Y.; Hirata, K.; Shimizu, T.; Li, Y.J.; Wakayama, Y. A forest bathing trip increases human natural killer activity and expression of anticancer proteins in female subjects. J. Biol. Regul. Homeost. Agents 2008, 22, 45-55.
180. Sadlon, A.E.; Lamson, D.W. Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices. Altern. Med. Rev. 2010, 15, 33-47.
181. Nam, J.H.; Jung, H.J.; Choi, J.; Lee, K.T.; Park, H.J. The anti-gastropathic and anti-rheumatic effect of nigaichigoside F1 and 23-hydroxytormentic acid isolated from the unripe fruits of Rubus Coreanus in a rat model. Biol. Pharm. Bull. 2006, 29, 967-970.
182. Oikawa, S. Sequence-specific DNA damage by reactive oxygen species: Implications for carcinogenesis and aging. Environ. Health Prev. Med. 2005, 10, 65-71.
183. Nose K. Role of reactive oxygen species in the regulation of physiological functions. Bio. Pharm. Bull. 2000, 23, 897-903.
184. Li, Q.; Nakadai, A.; Matsushima, H.; Miyazaki, Y.; Krensky, A.M.; Kawada, T.; Morimoto, K. Phytoncides (wood essential oils) induce human natural killer cell activity. Immunopharmacol. Immunotoxicol. 2006, 28, 319-333.
185. Komori, T.; Fujiwara, R.; Tanida, M.; Nomura, J.; Yokoyama, M.M. Effects of citrus fragrance on immune function and depressive states. Neuroimmunomodulation 1995, 2, 174-180.
186. Shibata, H.; Fujiwara, R.; Iwamoto, M.; Matsuoka, H.; Yokoyama, M.M. Immunological and behavioral effects of fragrance in mice. Int. J. Neurosci. 1991, 57, 151-159.